The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy
Abstract
Purpose: Circulating cell-free DNA is present in increased amounts in the blood of cancer patients, but the clinical relevance of this phenomenon remains unclear. We conducted a clinical study to assess the value of circulating DNA as a prognostic marker in patients with non–small-cell lung cancer (NSCLC). Patients and Methods: A standard protocol for the quantification of circulating DNA by real-time polymerase chain reaction was set up and validated at two oncology units. One hundred eighty-five informed patients with NSCLC and 46 healthy controls were included in the study. DNA concentrations were determined in paired plasma and serum samples and analyzed for a relationship with leukocyte counts and lactate dehydrogenase (LDH) levels. DNA concentrations in healthy controls and in patients were compared, and cutoff levels for plasma and serum DNA were determined. Patient survival was analyzed relative to baseline DNA concentrations, and the relationship between tumor responses and changes in DNA concentrations was assessed in patients receiving chemotherapy. Results: We found a significant correlation between increased plasma DNA concentrations and elevated LDH levels (P = .009), advanced tumor stage (P < .003), and poor survival (P < .001). Tumor progression after chemotherapy was significantly (P = .006) associated with increasing plasma DNA concentrations. Serum DNA concentrations strongly correlated (P < .001) with leukocyte counts. Conclusion: Our data demonstrate that quantification of plasma DNA is an accurate technique amenable to standardization, which might complement current methods for the prediction of patient survival. This approach might be considered for evaluation in large prospective studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
(1977) · PubMed · Cited by 1,801
Lo, Y. M. D., Tein, M. S. C., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M. K., Wainscoat, J. S., Johnson, P. J., Chang, A. M. Z., & Hjelm, N. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301800 · Cited by 1,653
Alberg, A. J., & Samet, J. M. (2010) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4160-4710-0.00046-8 · Cited by 1,060
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Alberg, A. J., Brock, M. V., & Samet, J. M. (2016) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4557-3383-5.00052-x · Cited by 781
Lui, Y. Y., Chik, K.-W., Chiu, R. W., Ho, C.-Y., Lam, C. W., & Lo, Y. D. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.421 · Cited by 578
Prognostic Factors in Non-small Cell Lung Cancer
Brundage, M. D., Davies, D., & Mackillop, W. J. (2002) · Chest · doi:10.1378/chest.122.3.1037 · Cited by 564
Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
Emlen, W., Niebur, J., & Kadera, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3685 · Cited by 552
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
Sozzi, G., Conte, D., Leon, M., Cirincione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.006 · Cited by 552
Sozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 421
Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
Fournié, G. J., Courtin, J.-P., Laval, F., Chalé, J.-J., Pourrat, J. P., Pujazon, M.-C., Lauque, D., & Carles, P. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03742-f · Cited by 268
Lung cancer in Europe in 2000: epidemiology, prevention, and early detection
Tyczynski, J. E., Bray, F., & Maxwell Parkin, D. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)00960-4 · Cited by 243
Circulating DNA: a new diagnostic gold mine?
Ziegler, A., Zangemeister-Wittke, U., & Stahel, R. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00077-4 · Cited by 228
Self-citationBearzatto, A., Conte, D., Frattini, M., Zaffaroni, N., Andriani, F., Balestra, D., Tavecchio, L., Daidone, M. G., & Sozzi, G. (2002) · PubMed · Cited by 144
Sozzi, G., Musso, K., Ratcliffe, C., Goldstraw, P. G., Pierotti, M. A., & Pastorino, U. (1999) · PubMed · Cited by 138
Ramírez, J. L., Sarries, C., Castro, P., Roig, B., Queralt, C., Escuín, D., de Aguirre, I., Sánchez, J. M., Manzano, J. L., Vila, M. M., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00740-1 · Cited by 121
Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients
An, Q., Liu, Y., Gao, Y., Huang, J., Fong, X., Li, L., Zhang, D.-C., & Cheng, S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00496-2 · Cited by 106
Thijssen, M. A. M. A., Swinkels, D. W., Ruers, T. J. M., & de Kok, J. B. (2002) · PubMed · Cited by 103
Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients
Beau‐Faller, M., Gaub, M. P., Schneider, A., Ducrocq, X., Massard, G., Gasser, B., Gaub, M. P., Kessler, R., Anker, P., Stroun, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11079 · Cited by 95
Use of Real-Time Quantitative PCR to Compare DNA Isolation Methods
de Kok, J. B., Hendriks, J. C. M., van Solinge, W. W., Willems, H. L., Mensink, E. J. B. M., & Swinkels, D. W. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.10.2201 · Cited by 68
Bruhn, N., Beinert, T., Oehm, C., Jandrig, B., Petersen, I., Xiaowei, C. H. E. N., Possinger, K., & Fleischhacker, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06594.x · Cited by 60
Cited by
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways
Hakim, M., Broza, Y. Y., Barash, O., Peled, N., Phillips, M., Amann, A., & Haick, H. (2012) · Chemical Reviews · doi:10.1021/cr300174a · Cited by 953
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Assessment, origin, and implementation of breath volatile cancer markers
Haick, H., Broza, Y. Y., Mochalski, P., Ruzsanyi, V., & Amann, A. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60329f · Cited by 644
Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature
Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337
Metadata
- Authors
- Gautschi, O., Bigosch, C., Huegli, B., Jermann, M., Marx, A., Chassé, E., Ratschiller, D., Weder, W., Joerger, M., Betticher, D. C., Stahel, R. A., & Ziegler, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-10-15
- Volume
- 22
- Issue
- 20
- Pages
- 4157-4164
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2100691227
- Cited by
- 275
- References
- 24
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.